STERIGENICS DENMARK A/S
CVR 26299691 · Public limited company (A/S) · Active · Low risk
STERIGENICS DENMARK A/S is a Public limited company (A/S), founded on , based in Espergærde. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 44.3m and a net result of DKK 24.3m.
Bankruptcy risk for STERIGENICS DENMARK A/S
0.0 × the average (1.41%) · higher risk than 15% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 26299691
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (25 years)
- Address
- Aa.Louis-Hansens Alle 11
3060 Espergærde - Municipality
- Helsingør
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 20.0m
- Employees
- 30 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 24 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 86.8% |
| Current ratio | 406% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 0 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 45.0m | DKK 44.4m | DKK 34.0m |
| Net profit | DKK 24.3m | DKK 25.5m | DKK 19.0m |
| Equity | DKK 44.3m | DKK 68.9m | DKK 121.7m |
| Total assets | DKK 51.1m | DKK 76.2m | DKK 127.3m |
| Cash | DKK 3.3m | DKK 5.1m | – |
| Short-term debt | DKK 6.5m | DKK 7.1m | – |
| Tax owed | DKK 0 | DKK 653k | – |
| Avg. employees | 43 | 45 | – |
Latest annual report: Reporting class B · auditor's statement: Den uafhængige revisors erklæring · EY.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 148 | ||
| 1 Jan 2024 – 31 Dec 2024 | 112 | ||
| 1 Jan 2023 – 31 Dec 2023 | 113 | ||
| 1 Jan 2022 – 31 Dec 2022 | 82 | ||
| 1 Jan 2021 – 31 Dec 2021 | 125 | ||
| 1 Jan 2020 – 31 Dec 2020 | 106 | ||
| 1 Jan 2019 – 31 Dec 2019 | 156 | ||
| 1 Jan 2018 – 31 Dec 2018 | 127 | ||
| 1 Jan 2017 – 31 Dec 2017 | 148 | ||
| 1 Jan 2016 – 31 Dec 2016 | 138 | ||
| 1 Jan 2015 – 31 Dec 2015 | 117 | ||
| 1 Jan 2014 – 31 Dec 2014 | 168 | ||
| 1 Jan 2013 – 31 Dec 2013 | 147 | ||
| 1 Jan 2012 – 31 Dec 2012 | 82 | ||
| 1 Jan 2011 – 31 Dec 2011 | 143 | ||
| 1 Jan 2010 – 31 Dec 2010 | 166 | ||
| 1 Jan 2009 – 31 Dec 2009 | 161 | ||
| 1 Jan 2008 – 31 Dec 2008 | 168 | ||
| 1 Jan 2007 – 31 Dec 2007 | 177 | ||
| 1 Jan 2006 – 31 Dec 2006 | 178 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Marc Markey | ||
| Board | Maja Nøddekær | Current | |
| Board | Robin Van Der Bergh | Current | |
| Board | Ronald Victor Asselberghs | Current | |
| Board | Dirk Kanel Lodewijk Barrie | ||
| Board | Jo Flor Toonn Lambrechts | ||
| Board | Jean Pierre Andre Francois Miralliè | ||
| Board | Marc Markey | ||
| Board | James Francis Clauser | ||
| Board | Lucianus Adrianus Christianus M. Bastiansen | ||
| Board | Hans Jozef Maria Aeschlimann | ||
| Board | Eric Hendrik E Meyers | ||
| Board | Verle Catharina A Van de Steen | ||
| Board | Kim Harboe | ||
| Board | Eddy Caspers | ||
| Board | Eric Meyers | ||
| Board | Sylvie Schottey | ||
| Board | Robin Van Der Bergh | ||
| Board | Lars Pontus Rundström | ||
| Owner (100%) | Nelson Labs BV | Current | |
| Owner (100%) | DEROSS Holding B.V. | ||
| Owner (100%) | STR 1 B.V. | ||
| Owner (100%) | Sterigenics NV | ||
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | PricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab | ||
| Auditor | EY Danmark A/S | ||
| Auditor | AAEN & CO. ApS | ||
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Founder | B.V. IBA S&I | Current | |
| Founder | B.V. IBA S&I |
Address history (1 moves)
| Aa.Louis-Hansens Alle 11, 3060 Espergærde | |
| Aa.Louis-Hansens Alle 11, 3060 Espergærde |
Former names
| STERIGENICS DENMARK A/S | – now |
| IBA S&I (DENMARK) A/S | – |
Employees per year
Similar companies in Helsingør
- Vima Med ApS Espergærde
- Ferle Aps. Hellebæk
- MoodHeadBand ApS Helsingør
- Wellness Nordic A/S Espergærde
- AMINO HEALTHCARE ApS Helsingør
- HD MEDICAL ApS Snekkersten
- ARION NORDIC ApS Helsingør
- New Life Company ApS Fredensborg
- Labmate ApS Hornbæk
- Siren Care Denmark IVS Hornbæk
- LASERLIGHT ApS Espergærde
- Selskabet af 1999 ApS Fredensborg
Questions and answers about STERIGENICS DENMARK A/S
Has STERIGENICS DENMARK A/S gone bankrupt?
No, STERIGENICS DENMARK A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of STERIGENICS DENMARK A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the auditor of STERIGENICS DENMARK A/S?
STERIGENICS DENMARK A/S most recently used EY Godkendt Revisionspartnerselskab.
When was STERIGENICS DENMARK A/S founded?
STERIGENICS DENMARK A/S was founded on 31 October 2001.
What is the equity of STERIGENICS DENMARK A/S?
Equity was DKK 44.3m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.